CIG
PFE icon

Cascade Investment Group’s Pfizer PFE Stock Holding History

Cascade Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452K Sell
18,782
-10,610
-36% -$278K 0.25% 90
2026
Q1 		$825K Buy
29,392
+503
+2% +$13.4K 0.54% 48
2025
Q4 		$719K Buy
28,889
+37
+0.1% +$933 0.48% 49
2025
Q3 		$735K Sell
28,852
-909
-3% -$22.4K 0.49% 50
2025
Q2 		$721K Sell
29,761
-110
-0.4% -$2.56K 0.5% 49
2025
Q1 		$757K Sell
29,871
-2,136
-7% -$55.9K 0.58% 45
2024
Q4 		$849K Buy
32,007
+1,277
+4% +$34.6K 0.61% 45
2024
Q3 		$889K Sell
30,730
-47
-0.2% -$1.37K 0.65% 44
2024
Q2 		$861K Buy
30,777
+1,704
+6% +$46.9K 0.67% 41
2024
Q1 		$807K Buy
29,073
+12,628
+77% +$350K 0.6% 43
2023
Q4 		$473K Buy
16,445
+3,665
+29% +$111K 0.38% 65
2023
Q3 		$424K Sell
12,780
-56
-0.4% -$1.98K 0.4% 61
2023
Q2 		$471K Sell
12,836
-1,976
-13% -$76.9K 0.43% 63
2023
Q1 		$604K Sell
14,812
-253
-2% -$10.9K 0.6% 47
2022
Q4 		$772K Buy
+15,065
New +$722K 0.8% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cascade Investment Group's PFE Position: Q2 2026 in Review

Cascade Investment Group reduced its Pfizer (PFE) stake by 36% in Q2 2026, selling an estimated $278K and leaving 18,782 shares worth $452K. The position accounts for 0.25% of the portfolio, ranked #90.

Cascade Investment Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $889K in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cascade Investment Group held 18,782 shares of Pfizer worth $452K as of Q2 2026.
  • Cascade Investment Group sold 10,610 Pfizer shares in Q2 2026, an estimated $278K.
  • Pfizer made up 0.25% of Cascade Investment Group's portfolio in Q2 2026, its #90 holding.
  • Cascade Investment Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Cascade Investment Group's Pfizer position peaked at $889K in Q3 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cascade Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.